Strauss -- Der Rosenkavalier, Final Trio -- K. Battle, F. von Stade, R. Fleming

This is a clip from the 1992 New Year's Eve Concert, Richard Strauß Gala in Berlin, Germany.
Wonderful performance by three gems of the opera world: 

Sophie: Kathleen Battle 

Octavian: Frederica von Stade 

Marschallin: Renee Fleming 

Recorded on December 31, 1992 in Berlin. 

Featuring:
Andreas Schmidt
Claudio Abbado
Berliner Philharmoniker

Link: https://youtu.be/EXi8U1twwrc

Relaxing Music: Elina Garanca - Bel Canto

Elina Garanca - Bel Canto / 2009

 

Михаил Коцеруба

Published on Jan 15, 2016

Meditation, Elina Garanca
http://www.deezer.com/album/8448975 

 01. Lucrezia Borgia Act 2 - Il segreto per esser felici 

02. L'assedio di Calais Act 1 - Al mio core 

03. Roberto Devereux Act 1 - All afflitto e dolce il pianto 

04. Dom Sebastien Roi de Portugal Act 2 - Que faire Sol adore de la patrie 

05. Adelson e Salvini Act 1 - Dopo l'oscuro nembo 

06. Maria Stuarda Act 1 - Si vuol di Francia il Rege 

07. Maria Stuarda Act 1 - Ah quando all ara scorgemi 

08. Maria Stuarda Act 1 - In tal giorno di contento 

09. Maria Stuarda Act 1 - Ah dal ciel discenda un raggio 

10. Tancredi Act 1 - Andante 

11. Tancredi Act 1 - O patria dolce e ingrata patria 

12. Tancredi Act 1 - Di tanti palpiti 

13. Maometto II Act 2 - Terzetto In questi estremi istanti 

14. I Capuleti e i Montecchi Act 1 - Lieto del dolce incarco 

15. I Capuleti e i Montecchi Act 1 - Ascolta se Romeo t uccise 

16. I Capuleti e i Montecchi Act 1 - Riedi al campo 

17. I Capuleti e i Montecchi Act 1 - La tremenda ultrice spada 

18. L assedio di Calais Act 2 - Io l udia

Category Music

Standard YouTube License

Music "Donizetti: Lucrezia Borgia / Act 2 - Il segreto per esser felici" by Elina Garanca 

(Google Play • iTunes)

Link: https://youtu.be/1U2m5nsyWNM

Does Parasitic Skin Disease - Morgellons - Even Exist? | NBC Left Field

Sound familiar? Rare conditions often go unrecognized by the medical establishment.

Thousands claim to have Morgellons, a condition that allegedly causes fibers to grow out of the skin.



A small team of researchers have linked it to Lyme disease, but here’s the thing: according to the Centers for Disease Control and Prevention and the majority of doctors, Morgellons does not exist, and there is “no common underlying medical condition” that explains reported symptoms.



Most doctors believe that Morgellons patients are actually suffering from a delusional disorder — and Morgellons is not recognized in diagnostic manuals.

Link: https://youtu.be/TJzHhGFOjNY

How bacteria in the gut influence neurodegenerative disorders

SfN: Neuroscience‏ @SfNtweets

Our last #SfN17 press conference of the day begins. Scientists will discuss how bacteria in the gut influence neurodegenerative disorders like #Parkinsons and #Alzheimers. 

Tracy Bale of @ummedschool moderates.

On her results: "[They] suggest that APOE alleles may differentially affect the gut microbiome...[contributing] to the actions of APOE in modulating Alzheimer’s disease risk."

  

Stem Cell and other potential treatments

#Stemcells cause remission of #MultipleSclerosis - improve quality of life. #FDA we need patient choice and approval. so we can live better

MS Unites‏ @MSUnites

MS & ME Internet Radio : MS, The Edge Live now! Listen here: http://msandme.out.airtime.pro:8000/msandme_a  - #ms #multiplesclerosis #CureMS #MSWarrior #MSNews

Labiotech.eu‏ @Labiotech_eu

#ifIcouldturnbacktime Hopefully this #MultipleSclerosis treaatment can! #GeNeuro #Servier #biotech ☛ https://goo.gl/6bC9oc 

   

Swiss Biotech and French Pharma Reverse Damage in Multiple Sclerosis

From The Clinic

Evelyn Warner on 01/11/2017

A candidate multiple sclerosis treatment from GeNeuro and its partner Servier showed some remyelination in a post hoc analysis of Phase IIb data.
GeNeuro’s stock rose by 30% on Monday following an announcement of promising results from its relapsing-remitting multiple sclerosis drug, GNbAC1. After six months, the highest dose demonstrated an anti-inflammatory effect and seemed to stimulate remyelination.
“When we released topline results after 24 weeks in August, we communicated that we had missed the primary endpoint: the cumulative number of gadolinium-enhancing lesions,” Jesús Martin-Garcia, CEO of GeNeuro, told us. “At the time, we formulated a hypothesis that this could be led by the late onset of action.”
GNbAC1 is a monoclonal antibody that targets a pathogenic retroviral envelope protein that has been found in all types and stages of multiple sclerosis. By neutralizing this protein, they reduced lesions and inflammation in the brain.  As Martin-Garcia described it, “We’re not directly impacting the immune system, like immunomodulating or immunosuppressive drugs. We’re neutralizing a pathogenic protein, so it may take longer for the effect to be seen on inflammatory markers.”

---

There are a number of companies working on a treatment for multiple sclerosis. Though Teva and Active Biotech recently faced a late-stage failure, Biogen has stepped up to the plate and recently recruited Swiss genomics outfit BC platforms.
So far, GeNeuro’s approach verges on unique: “There’s a tremendous amount of literature coming up today about pathogenic HERV proteins from leading research centers,” said Martin-Garcia. “But in the clinic, we’re really the only company.” Some academic centers are trying to treat the disease with antiretrovirals, which is the same concept but different tool.
So with the positive news in hand, what’s next for GeNeuro? “We have encouraging data here. Hopefully, we can open new avenues by neutralizing causal factors of these diseases, to slow down or stop their progression,” said Martin-Garcia. “Now we have to confirm how GNbAC1 performs after 48 weeks.” 
Curious? Hear more from the CFO of GeNeuro in our video interview.

---

Co-authored by Clara Rodríguez-Fernández

---

Images via Designua, ustas7777777 / shutterstock.com

Link: https://labiotech.eu/multiple-sclerosis-treatment-geneuro/?utm_source=twitter&utm_medium=social&utm_campaign=meetedgar

  

Water

 

How much water is enough, #RaynaudsDisease, #melatonin side effects, and more in #ConsumerHealth.

http://mayocl.in/2yWnAH6